Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 376-400 of 517 matching filings.

Per page
25
Current page
16
8-K File 001-16467

8-K

Filing date
04 Oct 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-40457

SCHEDULE 13D

Filing date
19 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-40457

SCHEDULE 13G

Filing date
19 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

SCHEDULE 13D AMENDMENT NO. 1

Filing date
19 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
09 May 2013
Reporting date
29 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
03 May 2013
Reporting date
29 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

CORTEX PHARMACEUTICALS INC--FORM 8-K

Filing date
05 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Apr 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
28 Mar 2013
Reporting date
22 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-40457

SCHEDULE 13D

Filing date
22 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2013
Reporting date
21 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-40457

SC 13D/A

Filing date
22 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
01 Nov 2012
Reporting date
26 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
04 Oct 2012
Reporting date
28 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8K

Filing date
01 Oct 2012
Reporting date
25 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-40457

SCHEDULE 13G

Filing date
19 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Sep 2012
Reporting date
10 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Sep 2012
Reporting date
10 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-183055

D filing

Filing date
22 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .